Loading…
Based on limited metadata, Mibo Medical Group, a medical device manufacturer, received an FDA Warning Letter on November 20, 2018. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's medical device regulatory authority, though the specific issuing office and violation count are not documented in this metadata summary. A complete review of the original Warning Letter would be necessary to identify the specific compliance issues cited.